Vicki L. Coffin
Affiliations: | Ross University School of Medicine |
Area:
Adenosine, dopamine, dopamine D1 receptors, NK1 antagonist, muscarinic M2 antagonist, caffeine, adenosine antagonistGoogle:
"Vicki Coffin"Mean distance: 18.34 (cluster 19) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Varty GB, Lu SX, Morgan CA, et al. (2008) The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510). The Journal of Pharmacology and Experimental Therapeutics. 326: 672-82 |
Shue HJ, Chen X, Schwerdt JH, et al. (2006) Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions. Bioorganic & Medicinal Chemistry Letters. 16: 1065-9 |
Shue HJ, Chen X, Shih NY, et al. (2005) Cyclic urea derivatives as potent NK1 selective antagonists. Bioorganic & Medicinal Chemistry Letters. 15: 3896-9 |
Wang Y, Chackalamannil S, Hu Z, et al. (2002) Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists. Journal of Medicinal Chemistry. 45: 5415-8 |
Boyle CD, Vice SF, Campion J, et al. (2002) Enhancement of pharmacokinetic properties and in vivo efficacy of benzylidene ketal M(2) muscarinic receptor antagonists via benzamide modification. Bioorganic & Medicinal Chemistry Letters. 12: 3479-82 |
Varty GB, Cohen-Williams ME, Morgan CA, et al. (2002) The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 371-9 |
Varty GB, Morgan CA, Cohen-Williams ME, et al. (2002) The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 357-70 |
Carey GJ, Billard W, Binch H, et al. (2001) SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. European Journal of Pharmacology. 431: 189-200 |
Boyle CD, Chackalamannil S, Clader JW, et al. (2001) Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitution. Bioorganic & Medicinal Chemistry Letters. 11: 2311-4 |
Greenlee W, Clader J, Asberom T, et al. (2001) Muscarinic agonists and antagonists in the treatment of Alzheimer's disease. Farmaco (Societã Chimica Italiana : 1989). 56: 247-50 |